FindTrial
Sign In

Clinical study on the prognosis of patients with heart failure by plasma cBIN1 score (CS)

Clinical study on the prognosis of patients with heart failure by plasma cBIN1 score (CS)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026310
Enrollment
Unknown
Registered
2019-09-29
Start date
2019-10-01
Completion date
Unknown
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure

Interventions

Case series:Nil

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Patients admitted to the cardiovascular internal medicine ward for heart failure from May 2019 to December 2019. (2) Aged 18 to 85 years old; (3) Meet the diagnostic criteria for heart failure set out in the Chinese guidelines for diagnosis and treatment of heart failure in 2018.

Exclusion criteria

Exclusion criteria: (1) Moderate or upper valvular insufficiency or stenosis; (2) acute myocardial infarction; (3) Patients with severe liver and kidney dysfunction, malignant tumors, etc.

Design outcomes

Primary

MeasureTime frame
cBIN1 scores;Cardiac death, hospitalization due to heart failure, cardiac function;—

Contacts

Public ContactLiu Yan

Department of Hypertension, Union Road Hospital, the First Affiliated Hospital of Dalian Medical University

15541191236@qq.com+86 18098875820

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026